Blueprint Medicines is a biopharmaceutical company working towards precision therapies designed to allow patients to live longer, healthier lives. We have multiple research programs for genomically defined cancers, rare disease and cancer immunotherapy. Our goal is to develop transformational medicines rooted in our leading expertise in protein kinases, which are proven drivers of disease. Our diverse team is passionate about science and thrives on working together to achieve the impossible. We use every opportunity to think differently, make bold decisions and pioneer novel solutions.
Explore our website to see how we’re creating a blueprint for a healthier tomorrow.